These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34977528)

  • 1. Cascade targeting codelivery of ingenol-3-angelate and doxorubicin for enhancing cancer chemoimmunotherapy through synergistic effects in prostate cancer.
    Wang Z; Sun C; Wu H; Xie J; Zhang T; Li Y; Xu X; Wang P; Wang C
    Mater Today Bio; 2022 Jan; 13():100189. PubMed ID: 34977528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential receptor-mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment.
    Shen J; Sun C; Wang Z; Chu Z; Liu C; Xu X; Xia M; Zhao M; Wang C
    Int J Pharm; 2021 May; 601():120553. PubMed ID: 33794325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG-PLA nanoparticles decorated with small-molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells.
    Afsharzadeh M; Hashemi M; Babaei M; Abnous K; Ramezani M
    J Cell Physiol; 2020 May; 235(5):4618-4630. PubMed ID: 31674023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune Cells.
    Zhan M; Qiu J; Fan Y; Chen L; Guo Y; Wang Z; Li J; Majoral JP; Shi X
    Adv Mater; 2023 Jan; 35(3):e2208277. PubMed ID: 36300810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases.
    Mu X; Zhang M; Wei A; Yin F; Wang Y; Hu K; Jiang J
    Nanoscale; 2021 May; 13(19):8998-9008. PubMed ID: 33973580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Prostate-Specific Membrane-Antigen (PSMA) Targeted Micelle-Encapsulating Wogonin Inhibits Prostate Cancer Cell Proliferation via Inducing Intrinsic Apoptotic Pathway.
    Zhang H; Liu X; Wu F; Qin F; Feng P; Xu T; Li X; Yang L
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity.
    Yang S; Shim MK; Kim WJ; Choi J; Nam GH; Kim J; Kim J; Moon Y; Kim HY; Park J; Park Y; Kim IS; Ryu JH; Kim K
    Biomaterials; 2021 May; 272():120791. PubMed ID: 33831739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer.
    Li K; Zhan W; Chen Y; Jha RK; Chen X
    Front Pharmacol; 2019; 10():1436. PubMed ID: 31920642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingenol-3-Angelate Suppresses Growth of Melanoma Cells and Skin Tumor Development by Downregulation of NF-κB-Cox2 Signaling.
    Wang D; Liu P
    Med Sci Monit; 2018 Jan; 24():486-502. PubMed ID: 29368698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma.
    Yu Z; Guo J; Hu M; Gao Y; Huang L
    ACS Nano; 2020 Apr; 14(4):4816-4828. PubMed ID: 32188241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nanotechnology-mediated immunochemotherapy with Ingenol-3-Mebutate for Systematic Anti-tumor Effects].
    Yu M; Zhao M; Yu R; Chu S; Xu J; Xia M; Wang C
    J Control Release; 2019 Jun; 304():242-258. PubMed ID: 31071376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detachable Nanoparticle-Enhanced Chemoimmunotherapy Based on Precise Killing of Tumor Seeds and Normalizing the Growing Soil Strategy.
    Wang L; Ding K; Zheng C; Xiao H; Liu X; Sun L; Omer R; Feng Q; Zhang Z
    Nano Lett; 2020 Sep; 20(9):6272-6280. PubMed ID: 32787161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade.
    Zhou F; Feng B; Yu H; Wang D; Wang T; Ma Y; Wang S; Li Y
    Adv Mater; 2019 Apr; 31(14):e1805888. PubMed ID: 30762908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heating tumors with tumor cell-derived nanoparticles to enhance chemoimmunotherapy for colorectal cancer.
    Li XY; Li RH; Cong JZ; Liu WS; Zhang Y; Guan HL; Zhu LL; Chen K; Pang LY; Jin H
    Nanomedicine (Lond); 2024 Mar; 19(7):561-579. PubMed ID: 38265008
    [No Abstract]   [Full Text] [Related]  

  • 15. Smart pH-Responsive Nanocube-Controlled Delivery of DNA Vaccine and Chemotherapeutic Drugs for Chemoimmunotherapy.
    Duong HTT; Thambi T; Yin Y; Lee JE; Seo YK; Jeong JH; Lee DS
    ACS Appl Mater Interfaces; 2019 Apr; 11(14):13058-13068. PubMed ID: 30888149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment.
    Wu B; Lu ST; Zhang LJ; Zhuo RX; Xu HB; Huang SW
    Int J Nanomedicine; 2017; 12():1853-1862. PubMed ID: 28331310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RasGRPs are targets of the anti-cancer agent ingenol-3-angelate.
    Song X; Lopez-Campistrous A; Sun L; Dower NA; Kedei N; Yang J; Kelsey JS; Lewin NE; Esch TE; Blumberg PM; Stone JC
    PLoS One; 2013; 8(8):e72331. PubMed ID: 23991094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death.
    Choi Y; Yoon HY; Kim J; Yang S; Lee J; Choi JW; Moon Y; Kim J; Lim S; Shim MK; Jeon S; Kwon IC; Kim K
    Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33260446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.